Discover open access scientific publications

Search, annotate, share and cite publications

Publications by J. Lee

P2.01-113 Prognostic Roles of Neoadjuvant and Adjuvant Chemotherapy for Treating Patients With Operable Stage III-N2 Non-Small Cell Lung Cancer (NSCLC)

Journal of Thoracic Oncology

English

P3.01-81 Long-Term Outcome of Surgically Resected Unsuspected N2 Lung Adenocarcinoma

Journal of Thoracic Oncology

English

P1.16-14 Impact of Smoking on Treatment Outcome in Early Squamous Cell Lung Cancer (T1N0)

Journal of Thoracic Oncology

English

P1.04-02 Targeting Established Lung Cancer Through Combination of DNT Cellular Therapy With PD1 Checkpoint Blockade

Journal of Thoracic Oncology

English

OA02.02 Safety and Preliminary Clinical Activity of Ropotrectinib (TPX-0005), a ROS1/TRK/ALK Inhibitor, in Advanced ROS1 Fusion-Positive NSCLC

Journal of Thoracic Oncology

English

P3.01-109 Real-World Patient-Reported Outcome Assessment of Patients With Metastatic Non-Small Cell Lung Cancer

Journal of Thoracic Oncology

English

OA11 First-Line Nivolumab + Ipilimumab in Asian Patients With Advanced NSCLC and High TMB (≥10 Mut/Mb): Results From CheckMate 227

Journal of Thoracic Oncology

English

PL02.03 Brigatinib vs Crizotinib in Patients With ALK Inhibitor-Naive Advanced ALK+ NSCLC: First Report of a Phase 3 Trial (ALTA-1L)

Journal of Thoracic Oncology

English

Binary Black Hole Population Properties Inferred From the First and Second Observing Runs of Advanced LIGO and Advanced Virgo

Astrophysical Journal Letters

English

P3.16-041 Pleural Photodynamic Therapy and Surgery for Pleural Metastasis by Non-Small Cell Lung Cancer

Journal of Thoracic Oncology

English

Amanote Research

Discover open access scientific publications

Search, annotate, share and cite publications

Publications by J. Lee

P2.01-113 Prognostic Roles of Neoadjuvant and Adjuvant Chemotherapy for Treating Patients With Operable Stage III-N2 Non-Small Cell Lung Cancer (NSCLC)

P3.01-81 Long-Term Outcome of Surgically Resected Unsuspected N2 Lung Adenocarcinoma

P1.16-14 Impact of Smoking on Treatment Outcome in Early Squamous Cell Lung Cancer (T1N0)

P1.04-02 Targeting Established Lung Cancer Through Combination of DNT Cellular Therapy With PD1 Checkpoint Blockade

OA02.02 Safety and Preliminary Clinical Activity of Ropotrectinib (TPX-0005), a ROS1/TRK/ALK Inhibitor, in Advanced ROS1 Fusion-Positive NSCLC

P3.01-109 Real-World Patient-Reported Outcome Assessment of Patients With Metastatic Non-Small Cell Lung Cancer

OA11 First-Line Nivolumab + Ipilimumab in Asian Patients With Advanced NSCLC and High TMB (≥10 Mut/Mb): Results From CheckMate 227

PL02.03 Brigatinib vs Crizotinib in Patients With ALK Inhibitor-Naive Advanced ALK+ NSCLC: First Report of a Phase 3 Trial (ALTA-1L)

Binary Black Hole Population Properties Inferred From the First and Second Observing Runs of Advanced LIGO and Advanced Virgo

P3.16-041 Pleural Photodynamic Therapy and Surgery for Pleural Metastasis by Non-Small Cell Lung Cancer